Biotech startup Ixchel Scientific hopes to bring higher success rates to trialed cancer drugs using an environment that better represents the human body.
The YC-backed startup does this by taking cancer cells that would normally be tested in a cold, hard plastic dish and puts them in the proteins of human organs instead. “Our composition of our cultures mimics what is in those… Read More...